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drocytes with regard to inﬂammation and its impact on metabolic activity.
Methods: Human chondrocytes were isolated from post-surgery dis-
carded human osteoarthritic articular cartilage. Expression of b2-adren-
ergic receptor on articular cartilage was tested with standard
immunohistochemical analysis. Employing 3D cell cultures in ﬁbringel,
effects of norepinephrine on interleukin-1b induced gene expression of
pro-inﬂammatory cytokines and matrix metalloproteinases (MMP) were
analyzed with quantitative real-time PCR. The impact of norepinephrine
on cell proliferation was determined in monolayer culture with BrdU and
XCelligence analyses.
Results: ß2-adrenergic receptors are abundantly expressed in human
osteoarthritic cartilage. Stimulation with norepinephrine has signiﬁcantly
reduced interleukin-1b induced gene expression of interleukin 8 and
MMP-13 in human osteoarthritic chondrocytes cultured in 3D ﬁbringel.
Notably, we were unable to detect an impact on interleukin-1b induced
gene expression of interleukin-6, MMP-2 and MMP-3. Furthermore,
norepinephrine inhibits BrdU incorporation compared to the controls.
Additionally, we measured a lower cell spreading, assessed through elec-
trical impedance using the XCelligence System (Roche), starting 6 h after
norepinephrine stimulation until analysis was stopped (50 h after stimu-
lation). All effects were observed exclusively with 10-6 M and not with 10-
8 M norepinephrine indicating for a signaling via b-adrenergic receptors.
Conclusions: Neurotransmitters of the sympathetic nervous system like
norepinephrine presumably mediate an anti-inﬂammatory / chon-
droprotective effect in human osteoarthritic chondrocytes via reducing
interleukin-8 and MMP-13. Furthermore, norepinephrine is able to
modulate the metabolic activity by inhibiting cell proliferation of human
osteoarthritic chondrocytes. These ﬁndings indicate, together with b2-
adrenergic receptor expression in human osteoarthritic articular cartilage,
a yet unknown function of catecholaminergic neurotransmitters in adult
human cartilage and might have an impact on osteoarthritis pathology.
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EGR-1 MEDIATES THE SUPPRESSIVE EFFECT OF IL-1 ON PPARG
EXPRESSION IN HUMAN OA CHONDROCYTES
S. Nebbaki, F. El Mansouri, N. Zayed, M. Benderdour, J. Martel-Pelletier,
J.-P. Pelletier, H. Fahmi. Univ. of Montreal, Montreal, QC, Canada
Purpose: PPARg has been shown to down-regulate several inﬂammatory
and catabolic responses in articular cartilage and chondrocytes and to be
protective in animal models of OA. We have previously shown that IL-1
down-regulated PPARg expression in OA chondrocytes. In the present
study we will investigate the mechanisms underlying this effect of IL-1.
Methods: Chondrocytes were stimulated with IL-1, and the level of PPARg
and Egr-1 protein and mRNA were evaluated using Western blotting and
real-time reverse-transcription polymerase chain reaction, respectively.
The PPARg promoter activity was analyzed in transient transfection
experiments. Egr-1 recruitment to the PPARg promoter was evaluated
using chromatin immunoprecipitation (ChIP) assays. Small interfering RNA
(siRNA) approaches were used to silence Egr-1 expression.
Results: We demonstrated that the suppressive effect of IL-1 on PPARg
expression requires de novo protein synthesis and was concomitant with
the induction of the transcription factor Egr-1. ChIP analyses revealed that
IL-1 induced Egr-1 recruitment at the PPARg promoter. IL-1 inhibited the
activity of PPARg promoter and overexpression of Egr-1 potentiated the
inhibitory effect of IL-1, suggesting that Egr-1 maymediate the suppressive
effect of IL-1. Finally, Egr-1 silencing with small interfering RNA blocked
IL-1-mediated down-regulation of PPARg expression.
Conclusion: These results indicate that Egr-1 contributes to IL-1-mediated
down-regulation of PPARg expression in OA chondrocytes and suggest that
this pathway could be a potential target for pharmacologic intervention in
the treatment of OA and possibly other arthritic diseases.
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THE FUNCTIONAL EFFECTS OF DIO2 IN AN IN-VITRO MODEL FOR
CHONDROGENESIS
N. Bömer 1, Y.F. Ramos 1, S.D. Bos 1,2, B.J. Duijnisveld 3, W. Koevoet 4,
G.J. van Osch 4,5, R.G. Nelissen 3, P.E. Slagboom1,2, I. Meulenbelt 1,2. 1Dept.of Molecular Epidemiology, LUMC, Leiden, Netherlands; 2 The Netherlands
Genomics Initiative-sponsored Netherlands Consortium for Hlth.y Aging
(NGI-NCHA), Leiden, Netherlands; 3Dept. of Orthopedics, LUMC, Leiden,
Netherlands; 4Dept. of Otorhinolaryngology, Erasmus MC, Rotterdam,
Netherlands; 5Dept. of Orthopedics, Erasmus MC, Rotterdam, Netherlands
Purpose: Previously, we identiﬁed the deiodinase iodothyronine type-2
gene (DIO2) as a relevant susceptibility gene for osteoarthritis (OA). The
type 2 deiodinase (D2) is a selenoprotein responsible for catalyzing the
conversion of intracellular inactive thyroid (T4) to active thyroid (T3),
a process that occurs in speciﬁc tissues including the growth plate. In the
growth plate, T3 speciﬁcally signals terminal maturation of the chon-
drocytes. Here, we investigate the role of DIO2 during chondrogenesis by
interfering with D2 protein function in an in-vitro chondrogenesis model.
Methods: The ‘RAAK’ study contains human bone marrow derived
mesenchymal stem cells (BM-MSCs) which were isolated from OA affected
hips joints of subjects undergoing total hip arthroplasty. These BM-MSCs
were cultured as micromasses and differentiated into cartilage particles.
First, we assessed expression of DIO2 at consecutive weeks of chondro-
genesis by RT-qPCR on samples previously isolated by the Rotterdam
departments. Next, we tested the RAAK samples for the effect of T3 and
Iodopanoic Acid (IOP), a DIO2 inhibitor, on chondrogenesis by adding them
to the chondrogenic culture medium of the micromass cultures. These
micromass cultures were than maintained up to 49 days. To measure the
effects of interfering with D2 protein function we initially assessed pellet
sizes at different time points and histochemistry with Alcian blue to
determine glycosaminoglycan and Alizarin red to determine calciﬁcations.
Results: DIO2 gene expression signiﬁcantly increased in untreated BM-
MSC micromasses during in-vitro chondrogenesis from 3 weeks onwards
of differentiation. Upon inhibition of DIO2 protein function with IOP, the
BM-MSC micromasses showed no signiﬁcant changes in size after 7 weeks
of differentiationwhen compared to untreated controls. In contrast, excess
of T3 resulted in signiﬁcantly smaller micromasses after 7 weeks of
differentiation suggesting decreased extracellular matrix deposition. This
observation was supported by histological analysis, which showed
decreased Alcian blue staining already after 5 weeks of differentiation in
T3 treated micromasses compared to untreated controls. In addition, only
upon treatment with T3, calcium deposition could be detected by Alizarin
Red staining from 5 weeks of differentiation onwards.
Conclusions: In addition to the association between DIO2 and osteoar-
thritis and the body of literature on the role of DIO2 in endochondral
ossiﬁcation, we are investigating the functional effect of DIO2 on chon-
drogenesis. Our ﬁrst results show a signiﬁcant up-regulation of DIO2 gene
expression during chondrogenic differentiation. Furthermore, we show
that excess T3 in this in-vitro chondrogenesis model, appears to interfere
with the chondrogenesis process reﬂected by signiﬁcant decreased pellet
sizes and decreased Alcian blue staining accompanied by increased
calcium deposition. Currently, we are using both lentiviral-induced DIO2
over expression and siRNA knock-down to explore directly the effect of
DIO2 interference during in-vitro chondrogenesis.
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EXPRESSION OF NUCLEOSTEMIN IN SYNOVIAL TISSUES AND IN
NORMAL AND OSTEOARTHRITIC CHONDROCYTES
M. Ricketts, D.M. Salter, S.H. Ralston. Univ. of Edinburgh, Edinburgh, United
Kingdom
Purpose: Osteoarthritis is a common disease with a strong genetic
component. Despite this, previous attempts to identify genetic variants
that predispose to osteoarthritis have met with limited success. In the past
few months, the results of a large genome wide association study for
osteoarthritis have been reported and identiﬁed a novel susceptibility
locus for the disease on chromosome 3 (Panoutsopoulou et al OARSI 2011).
The strongest association within this region was found with a SNP located
within the coding region of GNL3 gene which encodes nucleostemin
(p¼7.24x10-11). Nucleostemin is a protein that is found within the nucle-
olus of stem cells and tumour cells. It is thought to play a role in regulating
cell cycle progression by modulating the action of p53, but its role in the
joint is unknown. Here we wanted to determine if nucleostemin was
expressed in articular chondrocytes and other joint tissues to determine if
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S146there was any dysregulation of expression in cartilage from patients with
osteoarthritis.
Methods and Results:We looked for expression of nucleostemin mRNA in
cartilage, bone and synovial tissue by RT-PCR and this conﬁrmed expres-
sion of full length transcripts from all three tissues. Further studies using
western blotting showed that nucleostemin was expressed in cultured
articular chondrocytes and that expression levels (corrected for GAPDH)
were slightly higher in chondrocytes cultured from OA cartilage (n¼5)
versus those cultured from normal cartilage (n¼4) (0.900.12 vs.
0.590.11) although the differences were not signiﬁcant (p¼0.12). Nucle-
ostemin protein was also detected by western blotting in fresh extracts of
articular cartilage. Analysis of fresh and cultured articular chondrocytes by
immunohistochemistry showed evidence of nucleostemin expression
localised to the nucleoli.
Conclusions: We conclude that nucleostemin is expressed within several
articular tissues including chondrocytes where it is localised within the
nucleoli. Although we found that levels of protein expressionwere slightly
raised in osteoarthritic chondrocytes as compared with normal chon-
drocytes, the number of samples studied was small and this will have to be
conﬁrmed by further research.
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DELPHINIDIN BLOCKS IL-1b-INDUCED ACTIVATION OF NF-kB BY
MODULATING THE IKKb GENE EXPRESSION AND THE ACTIVATION OF
NIK IN HUMAN CHONDROCYTES
A. Haseeb, D. Chen, T.M. Haqqi. MetroHlth. Med. Ctr./CWRU, Cleveland, OH,
USA
Purpose: Osteoarthritis (OA) is a highly prevalent disease that affects the
quality of life of its victims. Interleukin-1 b (IL-1b) plays a major role in the
pathogenesis of OA and is present in the arthritic joints at high levels. IL-1b
has been shown to cause increased production of catabolic enzymes such
as MMPs, and inﬂammatory mediators such as prostaglandins and nitric
oxide through the activation of several signaling pathways including NF-
kB. Novel approaches using plant derived polyphenols to inhibit signal
transduction pathways have shown promise and could overcome some of
the toxicity issues related to current therapies. One key signaling mecha-
nism implicated in OA that could be a target of orally bioavailable inhibi-
tors is the NF-kB pathway. Delphinidin (2-(3,4,5-trihydroxyphenyl)
chromenylium-3,5,7-triol) is an anthocyanidin that is widely distributed in
pigmented fruits and ﬂowers and has been shown to possess anti-
inﬂammatory activity and block the activation of NF-kB in cancer cells. No
such study with human chondrocytes has been reported. In the present
study using primary human chondrocytes we determined (a) the chon-
droprotective effect of Delphinidin; and (b) mechanism of NF-kB inhibition
in IL-1b-stimulated human chondrocytes.
Methods: Chondrocytes were derived by enzymatic digestion of human
cartilage (OA chondrocytes) from patients undergoing total knee arthro-
plasty. OA chondrocytes were pretreated with Delphinidin for different
time points and were then stimulated with IL-1b (10ng/ml) in vitro and
total RNA or cell lysate was prepared following our standard protocols. To
determine the gene expression, single stranded cDNAwas synthesized and
the expression of target mRNAs (COX-2, MMP-13, iNOS) was quantiﬁed
using TaqMan Assays. HeLa cells were transfected with promoter reporter
vectors and negative control vectors using the Fugene-6 reagent and the
effect on promoter activity was veriﬁed by Luciferase assay. Activation of
NF-kB p65 was determined by speciﬁc ELISA-based DNA binding assay.
Total protein levels were determined by detergent compatible Biorad
Protein Assay. Nitric oxide production was determined by Griess reaction.
Protein expression and the phosphorylated forms of different kinases were
determined byWestern immunoblotting. Data were analyzed using Origin
6.1 software package and p<0.05 was considered signiﬁcant.
Results: Pretreatment of chondrocytes with Delphinidin (50 mg/ml) for 2
hrs signiﬁcantly inhibited the IL-1b induced expression of COX-2, iNOS and
MMP-13 and the production of nitric oxide. Delphinidin also inhibited the
phosphorylation of IKKb and was also a potent suppressor of IKKb gene
and protein expression in OA chondrocytes. IKK promoter had a strong
activity in HeLa cells and this activity and production of the Luciferase
reporter enzyme was blocked by pre-treatment with Delphinidin. Func-
tional pathway analyses showed that IL-1b-induced phosphorylation ofNF-kB-inducing Kinase (NIK), which interacts with and activates IKKa and
IKKb which then phosphorylate IkB, was inhibited by pretreatment of OA
chondrocytes with Delphinidin. In agreement with these ﬁndings, pre-
treatment with Delphinidin inhibited the phosphorylation and degrada-
tion of IkB, as determined by Western immunoblotting, and the activation
and the DNA binding activity of NF-kB p65 determined by a highly speciﬁc
ELISA based assay.
Conclusions: Taken together, the data presented here identiﬁes a novel
mechanism of NF-kB inhibition by Delphinidin by inhibiting NIK, a kinase
upstream of IKK complex in the NF-kB activation pathway. Given the
important role played by IL-1b and NF-kB in OA, these results may provide
important clues to develop useful pharmacological inhibitors of NF-kB for
the prevention and/or treatment of OA.
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REDIFFERENTIATION OF HUMAN ARTICULAR CHONDROCYTES IN 2D
VERSUS 3D CULTURE
M.J. Caron, P.J. Emans, L. Voss, D.A. Surtel, M.M. Coolsen, L.W. van Rhijn,
T.J. Welting. Dept. Orthopaedic Surgery, Maastricht Univ. Med. Ctr.,
Maastricht, NETHERLANDS
Purpose: For cartilage regenerative techniques human articular chon-
drocytes (HACs) are cultured in vitro. Unfortunately, long expansion time
and multiple passaging lead to ‘dedifferentiation’. To overcome dediffer-
entiation, chondrocytes are ‘redifferentiated’ in 3D-culturemodels (pellets,
alginate cultures etc.). However, 2D (monolayer) culture methods are less
laborious and have better reproducibility. We therefore set out to compare
redifferentiation characteristics of HACs in 2D and 3D systems
Methods: HACs were expanded in monolayer from 15 independent
donors. Redifferenitiation in monolayer was performed at subconﬂuency.
Identical medium conditions were used to redifferentiate cells in pellets or
alginate beads. After 7 days chondrogenic marker-expression was
analyzed.
Results:Monolayer redifferentiation did not support expression of Col2a1
and Sox9 mRNAs, whereas chondrocyte hypertrophy markers Col10A1,
Runx2 and ALP were signiﬁcantly increased. Col2a1 and Sox9 mRNA
expression in HACs redifferentiated in pellets or alginate beads increased
signiﬁcantly, as did Col10a1 and RunX2. Suggesting that redifferentiation
in monolayer does not fully support a chondrogenic phenotype. However,
when corresponding protein samples were analyzed we detected
a profound upregulation of Col2A1 and Sox9 protein expression in
monolayer samples which was quantitatively equal to samples from 3D
cultures. Upregulation of RunX2 and Col10A1 protein expression was also
found in both culture systems, with the monolayer cultures inducing these
markers to higher levels than 3D cultures.
Conclusions: For the ﬁrst time redifferentiation capacity of HACs was
compared between 2D and 3D culture techniques by gene expression as
well as by protein expression. Although gene expression analyses indicate
that monolayer does not support chondrogenic redifferentiation, protein
expression analysis proved the opposite. Besides a fundamentally inter-
esting contradictory observation, our data show that redifferentiation of
HACs is possible in monolayer but behaves differently on the gene
expression as compared to 3D culture systems. Monolayer provides
a reproducible and low cell amount-demanding culturesystem better
suited for molecular and genetic interference studies into chondrocyte
biology.
289
IMPAIRMENT OF MITOCHONDRIAL 8-OXOGUANINE DNA GLYCOSYLASE
(OGG1) AGAINST ACCUMULATION OF 8-OXOGUANINE IN
OSTEOARTIRITIC CHONDROCYTES.
K. Yudoh, R. Karasawa. St. Marianna Univ. Sch. of Med., Kawasaki City, Japan
Purpose: It is well known that chondrocytes produce excess amounts of
reactive oxygen species (ROS) as well as proinﬂammatory cytokines and
chemokines in response to mechanical and chemical stresses. An oxidized
form of guanine, 8-oxo-7,8-dihydroxyguanine (8-oxoguanine) is a major
causative lesion for mutagenesis by ROS, since it can form a stable base pair
with adenine as well as with cytosine during DNA replication. 8-
